Bexarotene/mogamulizumabPsoriasis vulgaris exacerbation and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1877卷 / 1期

关键词：

D O I：

10.1007/s40278-021-03642-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：72 / 72

相关论文

共 50 条

[41] AntineoplasticsMyelosuppression and lack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 66 - 66
[42] AntineoplasticsFever and lack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 51 - 51
[43] AntifungalsHepatotoxicity and lack of efficacy: case report
Reactions Weekly, 2021, 1886 (1) : 52 - 52
[44] CarbamazepineRash and lack of efficacy: case report
Reactions Weekly, 2023, 1945 (1) : 148 - 148
[45] AntineoplasticsNeutropenia and lack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 89 - 89
[46] AntineoplasticsDiarrhoea and lack of efficacy: case report
Reactions Weekly, 2023, 1979 (1) : 46 - 46
[47] EnzalutamideInsomnia and lack of efficacy: case report
Reactions Weekly, 2022, 1907 (1) : 205 - 205
[48] LurasidonePseudothrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2022, 1900 (1) : 201 - 201
[49] AntineoplasticsDiarrhoea and lack of efficacy: case report
Reactions Weekly, 2023, 1966 (1) : 48 - 48
[50] AntineoplastincsOesophagitis and lack of efficacy: case report
Reactions Weekly, 2022, 1920 (1) : 72 - 72

← 1 2 3 4 5 →